How Biotechs can scale faster amid industry challenges
JLL’s new guide provides 5 strategies to remove the barriers and help life sciences companies prepare for the future
CHICAGO, Oct. 25, 2022 – Since 2013, scaling biotech companies – early stage and fast-growing companies – have brought two-thirds of new therapies to market, and, with billions of dollars of capital deployed into the life sciences sector, the opportunities for positive clinical impact are larger than ever before. Because of this massive and fast growth, these biotech and biopharma companies face specific challenges when it comes to space and infrastructure needs.
JLL’s free guide 5 Strategies to Help Scale Your Biotech Company Faster discusses real estate and infrastructure strategies to help these life sciences companies secure and create the space needed to attract talent and catalyze business growth.
“When a life sciences organization – or any business – is in growth mode, the right R&D, manufacturing and office space is essential to commercialization success,” said Travis McCready, Head of Life Sciences, Americas Markets, JLL. “When you scale up, aligning scientific goals with a real estate strategy ensures you have the most efficacious built environment. This subsequently allows the freedom to create an attractive and inspiring destination for employees to innovate and advance value creation.”
One of the five strategies outlined in the eBook, JLL advises scaling biotech companies to follow the talent. They can narrow down their ideal location by identifying which local markets offer access to a robust talent pipeline to support their young, growing business. JLL’s 2022 Life Sciences Research Outlook & Cluster Rankings provides direction on the top life sciences innovation communities based on their access to talent, funding and real estate infrastructure, all of which support current and future growth.
“When selecting a market, it’s important to understand the key components of what makes a successful life sciences ecosystem,” said Roger Humphrey, President, Life Sciences Work Dynamics, JLL. “These characteristics include access to talent, funding that leads to commercialization and real estate infrastructure to support further growth.”
To download and read the free guide, which includes tips on lease negotiations and setting best practices, click here.
JLL's vision is to reimagine the world of real estate, creating, finding, locating and operating safe and amazing spaces. JLL’s Life Sciences team of 3,000+ experienced professionals are a safe pair of hands to help biotechnology, pharmaceutical, medical devices organizations, investors and developers achieve their ambitions. JLL brings deep understanding of location analytics, project management, research advisory, financial incentives, transaction management, capital markets, real estate strategy and technology, facilities management, regulatory compliance and quality, and more. Our solutions help fuel innovation, enhance efficiency, improve financial performance and attract and retain top talent. Our team is trained and certified to operate within office and critical, regulated environments of lab and manufacturing space. To learn more, visit us.jll.com/lifesciences.
For more news, videos and research resources on JLL, please visit our newsroom.
JLL (NYSE: JLL) is a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. JLL is a Fortune 500 company with annual revenue of $19.4 billion, operations in over 80 countries and a global workforce of more than 102,000 as of June 30, 2022. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.